< Back to previous page

Publication

One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study)

Journal Contribution - Journal Abstract Conference Contribution

Journal: EUROPEAN JOURNAL OF NEUROLOGY

Volume: 27

Pages: 1144 - 1144

Publication year:2020

WoS Id: 000534616803153
Handle: http://hdl.handle.net/1942/31793

Accessibility:Closed